AKTS CIK: 2035832

Aktis Oncology, Inc.

  • United States
  • Technology
Metrics score locked — part of Premium
FY23
FY23
FY24
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
59.8
FY23:
100
FY24:
36.8
FY24:
301
FY25:
230
(positive)
Change from FY23 to FY25
millions USD
FY23:
89.1
FY23:
22.2
FY24:
33.0
FY24:
25.3
FY25:
34.6
Total assets
Change from FY23 to FY25
millions USD
FY23:
149
FY23:
122
FY24:
69.7
FY24:
326
FY25:
265

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
17.6
FY23:
6.24
FY24:
84.4
FY24:
18.8
FY25:
31.2
(negative)
Change from FY23 to FY25
millions USD
FY23:
45.1
FY23:
162
FY24:
42.5
FY24:
395
FY25:
380
(positive)
Change from FY23 to FY25
millions USD
FY23:
86.2
FY23:
−46.3
FY24:
−57.1
FY24:
−87.8
FY25:
−146
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
149
FY23:
122
FY24:
69.7
FY24:
326
FY25:
265

All amounts in millions USD Data source:Twelve Data